Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lyubov S. Al-Radi"'
Autor:
Irina V. Poddubnaya, Lyubov S. Al-Radi, Tatyana E. Byalik, Kamil D. Kaplanov, Valentina Z. Molostvova, Evgeniy A. Nikitin, Tatyana I. Pospelova, Vadim V. Ptushkin, Olga S. Samoilova, Elena A. Stadnik, Gayane S. Tumyan
Publikováno v:
Современная онкология, Vol 22, Iss 1, Pp 31-33 (2020)
Over the past decade, we have seen a significant change in modern approaches in the first-line treatment of chronic lymphocytic leukemia (CLL). The CLL-10 study data established the FCR regimen as the treatment of choice for younger patients with lim
Externí odkaz:
https://doaj.org/article/67aed2307be24cdebf0808eebbc30d52
Autor:
Elena Alexandrovna Semenova, Anastasia A. Vasilkonova, Aminat U. Magomedova, Irina Borisovna Kaplanskaya, Maria Dmitrievna Sanatko, Mikhail M. Karpukhin, Alexander V. Grzhimolovsky, Lyubov S. Al-Radi
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
Along with a silicone lymphadenitis in axillary lymph nodes there are few observations of siliconomas with other localization in the literature. We observed female patient of 34 years that had tumor mass in the spleen after 12 years from augmentation
Externí odkaz:
https://doaj.org/article/aa62beef487541fe8c31910ef62a9502
Autor:
Svetlana Yu, Smirnova, Lyubov S, Al-Radi, Tatyana N, Moiseeva, Eduard G, Gemdzhian, Igor A, Yakutik, Hunan L, Julhakyan, Vyacheslav A, Novikov, Gennady M, Galstyan, Andrey B, Sudarikov
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(7)
Standard therapy in hairy cell leukemia (HCL) is often impossible at the time of deep neutropenia/agranulocytosis with or without infectious complications; it is thus a complex therapeutic problem. Vemurafenib has been used to treat resistant HCL sin